文献速递关节外科

同期与分期双侧全髋关节置换术:收入与贡献毛利的匹配队列分析

Simultaneous Versus Staged Bilateral Total Hip Arthroplasty: A Matched Cohort Analysis of Revenue and Contribution Margin.
PubMed 文献 · J Arthroplasty · 2024-04-25

在一家高手术量骨科专科医院2011至2021年间接受同期双侧全髋关节置换术(simBTHA)或分期双侧全髋关节置换术(staBTHA)的患者中,经1:1倾向性匹配各纳入116例,比较两组收入、成本、贡献毛利(CM)及手术结局。结果显示simBTHA组总成本、直接成本和患者收入显著更低,但CM组间无显著差异,住院时间、手术时间、90天再入院、90天翻修及全因翻修均无显著差异。

要点

  • simBTHA组总成本和直接成本显著低于staBTHA组(均P < .001)。
  • 两组贡献毛利(CM)无显著差异(P = .361)。
  • 住院时间、手术时间、90天再入院、90天翻修及全因翻修均无显著差异。

核心结论

  • simBTHA手术收入低于staBTHA,但成本也更低,因此两种手术的贡献毛利相似。
  • 由于两种手术术后并发症率相似,作者认为需进一步研究以明确哪些患者可能在临床和患者报告结局方面从simBTHA或staBTHA中获益。

研究设计与样本

  • 回顾性匹配队列分析,纳入2011至2021年在一家高手术量骨科专科医院接受simBTHA(同日完成双侧手术)和staBTHA(一年内不同日完成手术)的患者。
  • 共识别1517例患者(simBTHA组139例,staBTHA组1378例),基于基线人口学特征进行1:1倾向性匹配后纳入232例(每组116例)。
  • 比较两组收入、成本、贡献毛利(CM)及手术结局,证据等级为III级。

主要发现

  • 与staBTHA组相比,simBTHA组总成本显著更低(P < .001)。
  • 与staBTHA组相比,simBTHA组直接成本显著更低(P < .001)。
  • 与staBTHA组相比,simBTHA组患者收入显著更低。
  • 两组贡献毛利(CM)无显著差异(P = .361)。
  • 两组住院时间(P = .173)、手术时间(P = .438)、90天再入院(P = .701)、90天翻修(P = .313)及全因翻修(P = .701)均无显著差异。

局限性

  • 作者指出需进一步研究以评估具体哪些患者在临床和患者报告结局方面可能从simBTHA或staBTHA中获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Though previous studies have demonstrated improved cost benefits associated with simultaneous versus staged bilateral total hip arthroplasty (simBTHA and staBTHA), further investigation is needed regarding the revenues and contribution margins (CMs) of these procedures. In this study, we compared revenue, CM, and surgical outcomes between simBTHA and staBTHA. METHODS: All patients who underwent simBTHA (both procedures completed the same day) and staBTHA (procedures completed on different days within one year) between 2011 and 2021 at a single high-volume orthopedic specialty hospital were identified. Of the 1,517 identified patients (n = 139 simBTHA, n = 1,378 staBTHA), 232 were included in a 1:1 propensity match based on baseline demographics (116 per cohort). Revenue, costs, CM, and surgical outcomes were compared between cohorts. RESULTS: Compared to staBTHA, simBTHA procedures had significantly lower total costs (P < .001), direct costs (P < .001), and patient revenue. There was no significant difference in CM between groups (P = .361). Additionally, there were no significant differences in length of stay (P = .173), operative time (P = .438), 90-day readmissions (P = .701), 90-day revisions (P = .313), or all-cause revisions (P = .701) between cohorts. CONCLUSIONS: Though simBTHA procedures have lower revenues than staBTHA, they also have lower costs, resulting in similar CM between procedures. As both procedures have similar postoperative complication rates, further research is required to evaluate specifically which patients may benefit from simBTHA versus staBTHA regarding clinical and patient-reported outcomes. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Rajahraman V, Ashkenazi I, Thomas J, et al. Simultaneous Versus Staged Bilateral Total Hip Arthroplasty: A Matched Cohort Analysis of Revenue and Contribution Margin. J Arthroplasty. 2024. PMID: 38677345. doi:10.1016/j.arth.2024.04.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。